Home/Filings/4/0001610717-24-000272
4//SEC Filing

WHITE MICHAEL ANTHONY 4

Accession 0001610717-24-000272

CIK 0001676725other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 4:26 PM ET

Size

11.0 KB

Accession

0001610717-24-000272

Insider Transaction Report

Form 4
Period: 2024-05-29
WHITE MICHAEL ANTHONY
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2024-05-29$36.23/sh27,649$1,001,588851 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-05-2928,50064,000 total
    Exercise: $12.86Exp: 2032-02-29Common Stock (28,500 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-29$12.86/sh+28,500$366,51028,500 total
  • Sale

    Common Stock

    2024-05-29$36.78/sh851$31,2970 total
Footnotes (4)
  • [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on February 22, 2024.
  • [F2]This transaction was executed in multiple trades in prices ranging from $35.68 to $36.655, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]This transaction was executed in multiple trades in prices ranging from $36.68 to $36.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

IDEAYA Biosciences, Inc.

CIK 0001676725

Entity typeother

Related Parties

1
  • filerCIK 0001890578

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:26 PM ET
Size
11.0 KB